[New viewpoints for indication for radiologic treatment in leukoses and retikuloses].
D000970:Antineoplastic Agents / Q000627:therapeutic use; D006689:Hodgkin Disease / Q000188:drug therapy / Q000532:radiotherapy; D006801:Humans; D007938:Leukemia / Q000532:radiotherapy*; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000532:radiotherapy; D007951:Leukemia, Myeloid / Q000188:drug therapy / Q000532:radiotherapy; D008206:Lymphatic Diseases / Q000532:radiotherapy*; D008224:Lymphoma, Follicular / Q000188:drug therapy / Q000532:radiotherapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy / Q000532:radiotherapy; D008722:Methods; D009101:Multiple Myeloma / Q000188:drug therapy / Q000532:radiotherapy; D010954:Plasmacytoma / Q000188:drug therapy / Q000532:radiotherapy; D011879:Radiotherapy Dosage
D000970:Antineoplastic Agents
Neuree Gesichtspunkte zur Indikationsstellung der radiologischen Terapie bei Leukosen und Retikulosen.